|

Durvalumab Injection Clinical Trials

2 actively recruiting trials

Also known as: Durvalumab

Pipeline

Phase 2: 1Phase 3: 1

Top Sponsors

  • Suzhou Suncadia Biopharmaceuticals Co., Ltd.1
  • Nanjing Leads Biolabs Co.,Ltd1

Indications

  • Cancer2
  • Advanced Solid Tumour1
  • Advanced Biliary Tract Cancer1

Other2 trials

A Clinical Trial of LBL-024 Combination Drug in Patients With Advanced Solid Tumours[Substudy 02(BTC&HCC)]
Phase 2
A Phase III Study of SHR-8068 in Combination With Adebrelimab and Platinum-Containing Chemotherapy Versus Durvalumab in Combination With Platinum-Containing Chemotherapy as First-line Treatment for Advanced Biliary Tract Cancer (BTC)
Phase 3

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.